Back

From bats to humans: uncovering ISG15 as a new resistance factor in type 1 diabetes

Martin-Vazquez, E.; Yi, X.; Fernandes Bonfim, M.; Jawurek, S.; Zimath, P. L.; Roca-Rivada, A.; Garcia Oliveira, J.; Costa-Junior, J. M.; Pattou, F.; Kerr-Conte, J.; Nacher, M.; Montanya, E.; Ilegems, E.; Wesley, J. D.; Title, A. C.; Yesildag, B.; Hagai, T.; Op de Beeck, A.; Eizirik, D. L.

2026-04-06 immunology
10.64898/2026.04.02.713107 bioRxiv
Show abstract

Viral infections are one of the main environmental factors triggering type 1 diabetes (T1D). Pancreatic alpha cells are more resistant than beta cells to diabetogenic viruses, partially explaining their survival in T1D. Similarly, bats have enhanced viral resistance, suggesting putative convergent evolution in antiviral mechanisms. Herein, we compared global gene expression in bat fibroblasts under basal conditions or exposed to double-stranded RNA to human alpha and beta cells and found that alpha cells exhibit greater similarity than beta cells to the antiviral responses of bat cells, as well as stronger intrinsic resistance to viral infection. Interferon-stimulated gene 15 (ISG15), a key regulator of antiviral responses in humans and bats, has higher expression in alpha compared to beta cells in five single-cell RNASeq datasets from human islet cells and in human induced pluripotent stem cell (hiPSC)-derived alpha-like cells. ISG15 knockdown in human insulin-producing EndoC-{beta}H1 cells and human islets increases apoptosis under basal conditions and after IFN exposure, exacerbates IFN responses and increases cell death and viral production after infection with the diabetogenic virus coxsackievirus B1, while its overexpression protects EndoC-{beta}H1 cells from the virus. Collectively, the present results demonstrate that alpha cells but not beta cells have similarities with the virus resistance gene program present in bats and identify ISG15 as an important factor for islet cells to cope with viral and diabetogenic stresses.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Cell Reports
1338 papers in training set
Top 0.2%
19.4%
2
Cell Discovery
54 papers in training set
Top 0.8%
6.3%
3
Cellular & Molecular Immunology
14 papers in training set
Top 0.3%
4.8%
4
Nature Communications
4913 papers in training set
Top 33%
4.8%
5
Cell Metabolism
49 papers in training set
Top 0.4%
3.6%
6
Protein & Cell
25 papers in training set
Top 0.7%
3.2%
7
iScience
1063 papers in training set
Top 6%
3.1%
8
eLife
5422 papers in training set
Top 29%
3.1%
9
Cell Death & Differentiation
48 papers in training set
Top 0.1%
2.7%
50% of probability mass above
10
Cell Host & Microbe
113 papers in training set
Top 2%
2.6%
11
PLOS Biology
408 papers in training set
Top 5%
2.6%
12
Immunity
58 papers in training set
Top 2%
2.1%
13
Communications Biology
886 papers in training set
Top 5%
2.1%
14
Cell
370 papers in training set
Top 9%
2.1%
15
Gastroenterology
40 papers in training set
Top 0.8%
2.1%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 32%
1.7%
17
Signal Transduction and Targeted Therapy
29 papers in training set
Top 0.7%
1.7%
18
Journal of Experimental Medicine
106 papers in training set
Top 2%
1.5%
19
Horticulture Research
43 papers in training set
Top 1%
1.3%
20
Journal of Clinical Investigation
164 papers in training set
Top 4%
1.3%
21
JCI Insight
241 papers in training set
Top 4%
1.3%
22
Frontiers in Immunology
586 papers in training set
Top 5%
1.2%
23
Advanced Science
249 papers in training set
Top 14%
1.2%
24
Nucleic Acids Research
1128 papers in training set
Top 15%
0.9%
25
Diabetes
53 papers in training set
Top 0.6%
0.9%
26
Frontiers in Genetics
197 papers in training set
Top 9%
0.8%
27
Cell Reports Medicine
140 papers in training set
Top 7%
0.8%
28
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 6%
0.7%
29
BMC Genomics
328 papers in training set
Top 6%
0.7%
30
Genome Medicine
154 papers in training set
Top 9%
0.7%